Becton, Dickinson and Company
One Becton Drive
Franklin Lakes
New Jersey
07417
United States
Tel: 201-847-6800
Fax: 201-847-6475
Website: http://www.bd.com/
862 articles about Becton, Dickinson and Company
-
BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
3/18/2024
BD, a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood collection tubes without compromising hygiene, safety or quality of the material.
-
New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
3/13/2024
BD, a leading global medical technology company, announced new data from a research study evaluating the impact of deploying automated dispensing cabinets in long-term care facilities and an off-site, long-term care pharmacy.
-
Dave Hickey Announces Intent to Retire from BD
2/27/2024
BD, a leading global medical technology company, announced that Dave Hickey has informed the company of his intent to retire from BD, effective July 1.
-
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
2/21/2024
BD announced a strategic partnership with Camtech Health, a digital health company focused on at-home health testing, to advance cervical cancer screening by offering the first-ever option for women in Singapore to self-collect a sample in the privacy of their own home.
-
BD to Present at Investor Healthcare Conferences - February 15, 2024
2/15/2024
BD, a leading global medical technology company, announced that it will present at the following healthcare conferences.
-
BD Reports First Quarter Fiscal 2024 Financial Results
2/1/2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal 2024, which ended December 31, 2023.
-
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
1/30/2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Techcyte, a world leader in artificial intelligence (AI) digital diagnostics, today announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging.
-
BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening
1/25/2024
BD announced a collaboration with the Kenyan Government through the National Cancer Institute-Kenya to advance access to critical cancer diagnostics for women in Kenya.
-
BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
1/23/2024
BD announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.
-
BD Board Declares Dividend - Jan 23, 2024
1/23/2024
The Board of Directors of BD announced it has declared a quarterly dividend of $0.95 per common share, payable on March 29, 2024 to holders of record on March 8, 2024.
-
BD Announces Webcast of Annual Meeting of Shareholders - Jan 05, 2024
1/5/2024
BD, a leading global medical technology company, announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024, at 1:00 p.m.
-
BD to Announce Financial Results for its First Quarter of Fiscal 2024
1/4/2024
BD, a leading global medical technology company, announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024.
-
BD to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/22/2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 10:30 am Eastern Time.
-
BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters
12/14/2023
Bactiguard Holding AB announces strengthened ties with leading global medical technology company Becton Dickinson & Company, Bactiguard's longest and strongest license collaboration.
-
BD Signs World Economic Forum's Zero Health Gaps Pledge
12/11/2023
BD, a leading global medical technology company, announced it signed the World Economic Forum's Zero Health Gaps Pledge, which reinforces the company's longstanding commitment to help expand access and improve health equity in under-resourced communities around the world.
-
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
12/7/2023
BD (Becton, Dickinson and Company) today announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.
-
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
11/30/2023
BD, a leading global medical technology company, launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters, central venous catheters, IV lines and other vascular access devices.
-
FDA Safety Communication Does Not Impact BD Syringes
11/30/2023
BD, a leading global medical technology company, issued the following statement regarding the U.S. Food and Drug Administration Safety Communication on evaluation of certain plastic syringes:.
-
BD Names Dr. Ronald Silverman as Chief Medical Officer
11/21/2023
BD, a leading global medical technology company, announced that Ronald Silverman, MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023.
-
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
11/14/2023
BD, a leading global medical technology company, announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 8:20 am Eastern Time.